Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiraLAX Solution Concentrate in Chronic Constipation
NCT01885104Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2013
- Primary completion
- Sep 2013
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
01
Overview
A Phase 2 trial of polyethylene glycol 3350 in functional constipation (FC), sponsored by Bayer. Started Apr 2013; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NCT01885104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885104.